Synthesis and Biological Evaluation of Some Novel Pyrimidine Derivatives
Kalpana Divekar*, Jani Hardik and S. Brahmani Priyadarshini
Department of Pharmaceutical Chemistry and Pharmaceutics, Dayananda Sagar College of Pharmacy. Kumaraswamy Layout. Bangalore – 560078. Karnataka State.
*Corresponding Author E-mail: jani_goldberg@yahoo.com
ABSTRACT:
Pyrimidines are the class of heterocyclic compounds of pharmaceutical importance. The compounds having pyrimidine ring moiety are associated with fungicidal, anti-inflammatory, anti-HIV, antioxidant and anti-tumor activities.
In the present study, an attempt was made to synthesize and characterize substituted pyrimidine derivatives and they were screened for antimicrobial and antioxidant activities by Filter disc method and DPPH method, respectively.
KEYWORDS: Pyrimidine, Antimicrobial activity, Antioxidant activity, Filter disc method
Free radicals are unstable molecules which have an odd number of electrons and therefore try to capture another electron from another molecule to become stable. While the molecule is now stable, the molecule which had its electron stolen is now a free radical itself due to not having the desired number of electrons to make the molecule stable. This situation obviously results in a chain reaction in which each newly created free radical seeks an electron to steal to make it stable, whilst creating a free radical itself1.
This process occurs naturally, and the human body performs this task in some situations for our benefit, such as when fighting off infection. Free radical formation and its damaging chain reaction can also be because of negative factors such as smoking, radiation and intense exercise. When this damage is excessive it is said antioxidants should be consumed to curb the free radical damage. For those who seek optimal health, antioxidants are often supplemented to reduce free radicals, with damage caused by free radicals also ever increasing with age.
The syntheses of pyrimidine have attracted the attention of chemists because of their potential pharmocodynamic properties. Recently much interest has been focused on the synthesis of pyrimidines possessing anti-inflammatory2, analgesic2, antimalarial3 and antioxidant4 and antiulcer5 activity.
Pyrimidine does not exist in nature but in the form of its different derivatives are found as a part of more complex systems and widely distributed. Therefore, the research on the synthesis of the pyrimidine and its analogues is an ongoing search.
EXPERIMENTAL:
The melting points of the synthesized compounds were determined by open capillary tubes and Thiel’s melting point apparatus. The reaction was monitored by TLC. The IR Spectras of the compounds were recorded on Shimadzu 1320 FT-IR spectrometer (KBr pellets method) and values of Vmax are reported in cm-1. Nuclear magnetic resonance spectra were obtained on DMM X-200 MHz Brookfield from Astrazeneca Pharma Ind. Ltd. Using cm-1 and chemical shift (δ) were reported in parts per million downfield from standard reference Tetramethylsilane (TMS).
Preparation of 3-acetyl coumarin:6
To a cooled suspension of a mixture of salicylaldehyde (0.5mol) and ethyl acetoacetate (0.5mol) piperidine (2ml) was added with shaking. The mixture was then maintained at freezing temperature for 2-3 hrs. Yellow coloured lumps were formed. These lumps were broken in cold ethanol. The precipitate obtained was filtered and recrystallized from warm glacial acetic acid to give needle shaped crystals.
IR KBr (cm-1): 3032 (Str, aromatic CH), 1739 (lactone C=O), 1678 (methyl C=O), 1552 (aromatic C=C), 1213 (-C-O-C-), 754 (B, aromatic CH)
Preparation of chalcone:6
Conventional method:
A mixture of 3-acetyl coumarin (2.67g, 0.01mol) and substituted aromatic aldehyde (1.49g, 0.01 mol) in 25ml ethanol, piperidine (2g) in 5ml ethanol was added dropwise. The mixture was heated and refluxed for 12 hours. After cooling, the product was separated out and washed with ethanol (20ml) .The product was recrystllized from glacial acetic acid.
Preparation of pyrimidine derivatives:7
Chalcone (0.01 mol) and Guanidine Nitrate (0.015mol) in absolute ethanol (10ml) were refluxed on water bath for 6 hours. The solvent was completely evaporated and residue was poured into ice cold water. The precipitate solid was collected by filtration.
IR KBr (cm-1): 3063 (-NH str), 3018 (Str, aromatic CH), 1649 (C=O), 1587 (C=N), 1440 (C=C), 1242 (-C-O-C-) 763 (B, aromatic CH), 688 (-C-Cl)
1H NMR (δ ppm): 7.9 (2H, S, NH2), 7.13 (1H, S, CH=C), 7.3 (1H, S, CH=C, pyran), 7.38-7.5 (m, 8H aromatic)
Preparation of chloroacetylated pyrimidine derivatives:8
To the above prepared derivatives (0.01mol), chloroacetyl chloride (0.012mol) was added and heated under reflux in dry benzene (20ml) for 3 hours on steam bath. Benzene was distilled off to a possible extent and cooled. The product resulted was filtered, washed with small portions of petroleum ether and dried. The product was purified by recrystallization from alcohol to get a crystalline solid.
IR KBr (cm-1): 3063 (-NH str), 3022 (Str, aromatic CH), 1739 (C=O), 1653 (C=O), 1585 (-C=N), 1444 (C=C), 1244 (-C-O-C-), 763 (B, aromatic CH), 690 (-C-Cl)
1H NMR (δ ppm): 7.9 (1H, S, NH), 7.1 (1H, S,-CH=C),7.3 (1H, S,CH=C, pyran), 7.38-7.5 (m, 8H aromatic ), 1.6 (2H, S, -CH2Cl)
SCHEME OF WORK
Table No.1: Physicochemical Properties of the synthesized pyrimidine derivatives
|
Compound No. |
Substituent R |
Molecular Formula |
Melting Point(0C) |
Yield (%) |
|
F1 |
C6H4Cl |
C21H13Cl2N3O3 |
145-148 |
58 |
|
F2 |
C6H4Br |
C21H13N3O3BrCl |
162-165 |
55 |
|
F3 |
C6H4 NO2 |
C21H13ClN4O5 |
109-112 |
57 |
|
F4 |
C6H4F |
C21H13N3O3FCl |
112-116 |
45 |
|
F5 |
C6H4OH |
C21H14ClN3O4 |
140-144 |
48 |
|
F6 |
C6H4 NO2 |
C21H13ClN4O5 |
152-156 |
56 |
|
F7 |
C6H3Cl2 |
C21H12Cl3N3O3 |
142-146 |
64 |
Antioxidant Activity:5
DPPH method:-
Chemicals:
DPPH (1, 1 diphenyl-2-picryl-hydrazyl), DMSO (dimetyl sulphoxide), Methanol
Preparation of different concentrations of compounds:
30mg of the drug was dissolved in 30 ml DMSO (1 mg/ml or 1000mg/ml solution).From the above solution, different dilutions such as 500mg/ml, 250mg/ml, 125mg/ml, 62.5mg/ml, 31.25mg/ml, 15.62mg/ml, 7.81mg/ml and 3.9mg/ml were prepared.
Preparation of DPPH stock solution:
21 mg of DPPH was placed in 100ml volumetric flask and methanol was added up to the mark.
Preparation of DPPH working solution:
18 ml of DPPH stock solution was pipetted out into a 100ml volumetric flask and diluted with methanol.
Procedure:
Sample:
0.25 ml of above dilutions (sample) were taken in a test tube and 5ml DPPH working solution was added into each test tube.
Sample blank:
0.25 ml of above dilutions (sample) were taken in a test tube and 5 ml of methanol was added into each test tube.
Control:
0.25ml of DMSO was taken in a test tube and then 5ml of DPPH working solution was added.
Control blank:
0.25ml of DMSO was taken in a test tube and then 5ml of methanol was added.
These test tubes were incubated at 37°C for 20min and the absorbance was determined by using UV spectrophotometer at 517nm.The % inhibition was calculated by using formula,
Control – Sample
% Inhibition = ------------------------------------------ X 100
Control
The IC50 value was obtained by plotting the graph, taking % inhibition on y axis and concentration on x axis.
Ascorbic acid:
Ascorbic acid was used as a standard and above procedure was followed to compare the antioxidant activity of different synthesized compounds with ascorbic acid.
Antimicrobial Studies:9
In our current study, the antimicrobial activity was carried out by the Filter disk method. Here responses of microorganisms to the synthesized compounds were measured and compared with the response of the standard reference drug. The standard reference drug used in the present work was Amoxicillin trihydrate.
Table No.2: Antioxidant activity of synthesized compounds
|
Sl. No |
Mole. Formula |
% Inhibition |
IC50 ± SEM DPPH Method |
|
1. |
C21H13Cl2N3O2 |
1.05 - 50.39 |
446.43 ± 2.830 |
|
2. |
C21H13N3O2BrCl |
5.31-43.19 |
> 500 |
|
3. |
C21H13ClN4O4 |
6.20 - 66.22 |
224.63 ± 1.097 |
|
4. |
C21H13N3O2FCl |
7.69 - 46.24 |
> 500 |
|
5. |
C21H14ClN4O4 |
4.61 - 56.59 |
475.23 ± 1.798 |
|
6. |
C21H13ClN4O4 |
2.24 - 54.08 |
374.93 ± 1.545 |
|
7. |
C21H13Cl2N3O2 |
8.92 - 48.02 |
>500 |
|
STD. |
Ascorbic acid |
45 - 98 |
13.33 ± 0.88 |
Preparation of test solutions:
Each test compound was dissolved in DMSO to get a concentration of 5mg/ml and 10 mg/ml. This concentration was used for testing antibacterial activity.
Procedure:
The petridishes were thoroughly washed and sterilized. Prepared Agar media was added into sterilized petridish and allowed it to get solidified. After solidification of media, 0.1ml of inoculum was added over it and spreaded for even distribution of organism. Here both high and low strength disks are applied for each antibiotic to be tested. The organism is reported as being sensitive if a clear zone appears around both disks. If the zone appears around the high concentration alone, the organism is called moderately susceptible. If zones are taking in both the disks, the organism is considered resistant to drug. 5µl of the sample was placed on the disk. Using the concentration of 5mg/ml and 10 mg/ml, samples were prepared in duplicate in each petridish. A standard (Amoxicillin trihydrate for antibacterial activity) was maintained with same concentration in another plate and a control having only DMSO in one plate. Then the petridishes were incubated at 37şC for 24hrs and zones of inhibition were observed and measured.
Table No.3: Antimicrobial activity of the synthesized compounds.
|
Comp. |
Zone of Inhibition(mm) |
||||
|
S. aureus |
S. pneumococci |
E. coli |
P. aeruginosa |
Klebsiella pneumoniae |
|
|
1 |
18 |
11 |
13 |
12 |
15 |
|
2 |
13 |
13 |
11 |
13 |
14 |
|
3 |
20 |
16 |
16 |
17 |
18 |
|
4 |
19 |
15 |
11 |
18 |
17 |
|
5 |
14 |
11 |
12 |
13 |
12 |
|
6 |
15 |
13 |
14 |
14 |
17 |
|
7 |
12 |
13 |
12 |
12 |
14 |
|
Amoxicillin trihydrate |
23 |
25 |
21 |
24 |
26 |
RESULTS AND DISCUSSION
The Physicochemical Properties of the synthesized pyrimidine derivatives is shown in table-1. The results (Table-3) indicates that in general Nitro, Flouro and Chloro derivatives out of seven prepared compounds showed good antibacterial activity against both Gram positive and Gram negative bacteria which were used for screening. None of the compounds showed significant antioxidant activity compared to Ascorbic acid (Table-2).
REFERENCES:
1. http://www.exrx.net/Nutrition/Antioxidants/Introduction.html
2. Sham M.Sondhi, Shubhi Jain, Monica Dinodia, Rakesh Shukla, Ram Raghubir. One pot synthesis of pyrimidine and bispyrimidine derivatives and their evaluation for anti-inflammatory and analgesic activities. Bioorg Med Chem 2007; 15 :3334-3344.
3. Anu Agarwal, Kumkum Srivastava, SK Puri, MS Chauhan. Antimalarial activity of 2, 4, 6-trisubstituted pyrimidines. Bioorg Med Chem Lett 2005; 15 :1881-1883.
4. Pham Cam Nam, Minh Tho Nguyen, Asit K Chandra. Theoritical Study of the Substituent Effects on the S-H Bond Dissociation Energy and Ionization Energy of 3-Pyridinethiol: Prediction of Novel Antioxidant. J Phys Chem A 2006; 110:10904-10911.
5. Shirwaikar Annie, HN Aswatha Ram, Mohpatra P. Antioxidant and Antiulcer activity of aqueous extract of a polyherbal formulation. Indian J of Experimental biology 2006; 44 (6):474-480.
6. BS Jayashree, Sameer Arora, KN Venugopala. Microwave assisted synthesis of substituted coumarinyl chalcones as reaction intermediates for biologically important coumarinyl heterocycles. Asian Journal of Chemistry 2008; 20 (1):1-7.
7. Sk A Rahaman, Y Rajendra Pasad, Phani Kumar, Bharath Kumar. Synthesis and Anti-histaminic activity of some Novel pyrimidines. Saudi Pharmaceutical Journal 2009; 17 (3):259-263.
8. V Murugan, KM Geetha, MS Sandhyavalli, S Badami. Synthesis and antioxidant activity of 5-[bis-2-(chloroethyl)-amino]4-substituted 6-phenyl pyrimidine-2-yl ethanethioate derivatives with Nitrogen mustards. Asian Journal of chemistry 2008; 20 (7):5166-5170.
9. Desai NC, Bhavsar AM, Shah MD, Saxena Anil K. Synthesis and QSAR studies of thiosemicarbazides, 1,2,4-triazoles, 1,3,4-thiadiazoles and 1,3,4-oxadiazoles derivatives as potential antibacterial agents. INDIAN J CHEM 2008; 47B: 579-589.
Received on 02.07.2010 Modified on 17.07.2010
Accepted on 30.07.2010 © AJRC All right reserved
Asian J. Research Chem. 4(1): January 2011; Page 64-67